| Clinical And Economic Impact Of Upfront Plerixafor In Autologous Transplantation (NCT01339572) | University of Florida | 2011-04-01 |
| Acetylic Salicylic Acid for the Treatment of Chronic Obstructive Pulmonary Disease (NCT01328145) | Medical University of Vienna | 2011-04-01 |
| Double-blind, Placebo-Controlled Pilot Study of Bupropion to Promote Smoking Cessation During Pregnancy (NCT01286402) | The University of Texas Health Science Center, Houston | 2011-04-01 |
| To Rescue Cognition With Valaciclovir (NCT01364792) | University Medical Center Groningen | 2011-04-01 |
| Study of Tocilizumab to Treat Polymyalgia Rheumatica (NCT01396317) | Hospital for Special Surgery, New York | 2011-04-01 |
| Efficacy of AC-170 for the Treatment of Allergic Conjunctivitis in the Conjunctival Allergen Challenge (CAC) Model (NCT01332188) | Aciex Therapeutics, Inc. | 2011-04-01 |
| Monotherapy of Itraconazole Versus Prednisolone in Allergic Bronchopulmonary Aspergillosis (NCT01321827) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2011-04-01 |
| Efficacy and Safety of the Prophylactic Use of Doxycycline +/- Vitamin K Cream (NCT01345526) | Universitätsmedizin Mannheim | 2011-04-01 |
| Consolidation Therapy With Hu3S193 for Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer (NCT01137071) | Recepta Biopharma | 2011-04-01 |
| A Pilot Efficacy and Safety Study of ST101 in Essential Tremor (NCT01332695) | Sonexa Therapeutics, Inc. | 2011-04-01 |
| Study to Evaluate Efficacy and Tolerance of R-GemOx in DLBCL and MCL (NCT01562977) | Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea | 2011-04-01 |
| Ibudilast in the Treatment of Medication Overuse Headache (NCT01317992) | University of Adelaide | 2011-04-01 |
| Topical Metronidazole and Miconazole Co-formulated Vaginal Suppositories for Preventing Vaginal Infections in HIV-seronegative Women (NCT01230814) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-04-01 |
| Acupressure for Persistent Cancer Related Fatigue (NCT01281904) | University of Michigan | 2011-04-01 |
| Chemotherapy for Patients With Locally Advanced Pancreatic Cancer (LAPC) With Additional Chemo-radiotherapy (CRT) for Patients With Borderline Resectable Tumours (NCT01397019) | Per Pfeiffer | 2011-04-01 |
| Vitamin D Supplementation in HIV-infected Youth (NCT01656070) | University of Milan | 2011-04-01 |
| Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two Steps (NCT01350258) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2011-04-01 |
| Study of Crenolanib for the Treatment of Patients With Advanced GIST With the D842-related Mutations and Deletions in the PDGFRA Gene (NCT01243346) | Arog Pharmaceuticals, Inc. | 2011-04-01 |
| Phase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic Disorders (NCT01372228) | Talaris Therapeutics Inc. | 2011-04-01 |
| The Water Method Colonoscopy in Routine Unsedated Colonoscopy Examinations (NCT01341847) | Gadjah Mada University | 2011-04-01 |
| New Dual Therapy for Primary Treatment of Helicobacter Pylori Infection：a Pilot Study (NCT01513785) | Shanghai Jiao Tong University School of Medicine | 2011-04-01 |
| Blood Lipid-lowering Effect of Brown Alga Ecklonia Cava (NCT02091024) | Chonbuk National University Hospital | 2011-04-01 |
| A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer (NCT01326000) | Hoffmann-La Roche | 2011-04-01 |
| Safety, Tolerability, and Pharmacokinetics of Iloperidone Depot in Schizophrenic Patients (NCT01348100) | Novartis Pharmaceuticals | 2011-04-01 |
| Attention Bias Modification Treatment for Children With Social Anxiety (NCT01397032) | Tel Aviv University | 2011-04-01 |
| Comparison of Drug Eluting Balloon and Drug Eluting Stent (NCT01539603) | Seoul National University Bundang Hospital | 2011-04-01 |
| A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck (NCT01059643) | Eli Lilly and Company | 2011-04-01 |
| A Study of a New Drug Treatment for Acne (NCT01326780) | Bausch Health Americas, Inc. | 2011-03-31 |
| A Study of Erlotinib in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutations (NCT01260181) | Hoffmann-La Roche | 2011-03-31 |
| A Study of the Efficacy and Safety of Vibegron (MK-4618) in Participants With Overactive Bladder (OAB) (MK-4618-008) (NCT01314872) | Merck Sharp & Dohme LLC | 2011-03-31 |
| Effects of Caloric Restriction Alone Versus Postoperative Caloric Restriction Following Bariatric Surgery on Glucose Metabolism in Patients With Diabetes Mellitus (NCT01083108) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2011-03-31 |
| A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (TRIGGER) (NCT01378962) | Hoffmann-La Roche | 2011-03-31 |
| A Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus (NCT01283139) | MedImmune LLC | 2011-03-31 |
| A Study of LY2157299 in Participants With Hepatocellular Carcinoma (NCT01246986) | Eli Lilly and Company | 2011-03-30 |
| A Study to Evaluate the Efficacy, Safety and Tolerability of Mirabegron and Solifenacin Succinate Alone and in Combination for the Treatment of Overactive Bladder (NCT01340027) | Astellas Pharma Europe B.V. | 2011-03-29 |
| Placebo Controlled Efficacy and Safety Study of CD2475/101 40 mg Tablets vs. Placebo and Doxycycline 100 mg Capsules Once Daily in the Treatment of Inflammatory Lesions of Acne Vulgaris (NCT01320033) | Galderma R&D | 2011-03-29 |
| IV Iron Replacement for Iron Deficiency in Idiopathic Pulmonary Arterial Hypertension (IPAH) Patients (NCT01447628) | Imperial College London | 2011-03-29 |
| To Determine Safe and Effective Dose of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Participants With Advanced Non-small Cell Lung Cancer (NCT01284348) | Merck Sharp & Dohme LLC | 2011-03-25 |
| Prospective Randomized Study of Cell Transfer Therapy for Metastatic Melanoma Using Tumor Infiltrating Lymphocytes Plus IL-2 Following Non-Myeloablative Lymphocyte Depleting Chemo Regimen Alone or in Conjunction With 12Gy Total Body Irradiation (TBI... (NCT01319565) | National Cancer Institute (NCI) | 2011-03-24 |
| A Phase II Study of Single Agent MEK162 in Patients With Advanced Melanoma (NCT01320085) | Pfizer | 2011-03-24 |
| Open-label Extension Study of Pridopidine (ACR16) in the Symptomatic Treatment of Huntington Disease (NCT01306929) | Prilenia | 2011-03-24 |
| Safety and Efficacy of LCI699 in Cushing's Disease Patients (NCT01331239) | Novartis Pharmaceuticals | 2011-03-23 |
| Assess the Feasibility and Efficacy of the CollaRx® Bupivacaine Implant Laparoscopic Inguinal or Umbilical Herniorrhaphy (NCT01224145) | Innocoll | 2011-03-22 |
| A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer (NCT01288911) | Astellas Pharma Inc | 2011-03-22 |
| Bevacizumab With or Without Fosbretabulin Tromethamine in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer (NCT01305213) | National Cancer Institute (NCI) | 2011-03-21 |
| A Trial to Assess the Safety, Tolerability and Immunogenicity of Repevax and rLP2086 Vaccine When Given Together in Healthy Subjects Aged >=11 to <19 Years. (NCT01323270) | Pfizer | 2011-03-18 |
| Efficacy and Safety Study of Idelalisib in Participants With Indolent B-Cell Non-Hodgkin Lymphomas (NCT01282424) | Gilead Sciences | 2011-03-18 |
| Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer (NCT01251861) | National Cancer Institute (NCI) | 2011-03-17 |
| Phase I/II Study of Ribavirin Given as Monotherapy in Solid Tumour Cancer Patients (NCT01309490) | Jewish General Hospital | 2011-03-17 |
| Cidofovir Versus Best Supportive Care for Hemorrhagic Cystitis (NCT01295645) | M.D. Anderson Cancer Center | 2011-03-17 |
| Maximal Androgen Depletion Followed by Randomization of Maximal Androgen Ablation With Molecular Targeted Therapies (NCT01254864) | M.D. Anderson Cancer Center | 2011-03-16 |
| A Pilot Study of a Thrombopoietin-Receptor Agonist, Eltrombopag, in Patients With Low to Int-2 Risk Myelodysplastic Syndrome (MDS) (NCT00961064) | National Heart, Lung, and Blood Institute (NHLBI) | 2011-03-15 |
| Erlotinib in Treating Patients With Recurrent or Metastatic Skin Squamous Cell Carcinoma (NCT01198028) | M.D. Anderson Cancer Center | 2011-03-10 |
| Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure (NCT01335932) | Fred Hutchinson Cancer Center | 2011-03-10 |
| Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS) (NCT01276236) | University of California, San Francisco | 2011-03-09 |
| Study of the Combination of Panitumumab With Paclitaxel as First-line Treatment of Subjects With Head and Neck Cancer (NCT01264328) | Grupo Español de Tratamiento de Tumores de Cabeza y Cuello | 2011-03-09 |
| Efficacy and Safety Study of GM602 in Patients With Acute Middle Cerebral Artery Ischemic Stroke Within 18 Hours (NCT01221246) | Genervon Biopharmaceuticals, LLC | 2011-03-08 |
| Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma (NCT01199978) | Massachusetts General Hospital | 2011-03-08 |
| A Trial of FANG™ Vaccine for Participants With Ovarian Cancer (NCT01309230) | Gradalis, Inc. | 2011-03-08 |
| Study of Hepatic Arterial Infusion With Intravenous Irinotecan, 5FU and Leucovorin With or Without Panitumumab, in Patients With Wild Type RAS Who Have Resected Hepatic Metastases From Colorectal Cancer (NCT01312857) | Memorial Sloan Kettering Cancer Center | 2011-03-07 |
| Open-label Study to Assess the Safety and Efficacy of CDP6038 (Olokizumab) in Patients Who Completed RA0056 (NCT01296711) | UCB BIOSCIENCES, Inc. | 2011-03-07 |
| Phase 2 Study of Maintenance OSI-906 Plus Erlotinib (Tarceva®), or Placebo Plus Erlotinib in Patients With Nonprogression Following 4 Cycles of Platinum-based Chemotherapy (NCT01186861) | Astellas Pharma Inc | 2011-03-04 |
| Dose Dense Doxorubucin and Cyclophosphamide Followed by Eribulin Mesylate for the Adjuvant Treatment of Early Stage Breast Cancer (NCT01328249) | Eisai Inc. | 2011-03-03 |
| Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects (NCT01177540) | Eisai Inc. | 2011-03-03 |
| A Trial To Assess The Safety, Tolerability, And Immunogenicity Of Rlp2086 Vaccine When Administered In Either 2- Or 3-Dose Regimens In Healthy Subjects Aged ≥11 To <19 Years (NCT01299480) | Pfizer | 2011-03-03 |
| Open Label Extension Study of Conatumumab and Ganitumab (AMG 479) (NCT01327612) | Amgen | 2011-03-03 |
| Safety and Efficacy Study of PLX3397 in Adults With Relapsed or Refractory Hodgkin Lymphoma (NCT01217229) | Daiichi Sankyo | 2011-03-03 |
| Erlotinib as Neoadjuvant Treatment in Patients With Stage ⅢA N2 NSCLC With Activating EGFR Mutation. (NCT01217619) | Baohui Han | 2011-03-02 |
| Extension of Study HGT-SAN-055 Evaluating Administration of rhHNS in Patients With Sanfilippo Syndrome Type A (MPS IIIA) (NCT01299727) | Shire | 2011-03-01 |
| Safety and Efficacy Study of CENV3 Vaccine to Protect Against HCV Infection (NCT01718834) | National Liver Institute, Egypt | 2011-03-01 |
| Vitamin D Supplementation and Cardiac Hypertrophy in Chronic Kidney Disease (CKD) (NCT01323712) | St George's, University of London | 2011-03-01 |
| Nutrition and Body Composition in Acute Lymphoblastic Leukemia (NCT01317940) | Children's Hospital Los Angeles | 2011-03-01 |
| OZURDEX in Age Related Macular Degeneration as Adjunct to Ranibizumab (NCT01243086) | McMaster University | 2011-03-01 |
| Study to Assess Safety and Efficacy of Anti-Interleukin 6-receptor (IL6R) Nanobody in Rheumatoid Arthritis (RA) Patients (NCT01284569) | Ablynx, a Sanofi company | 2011-03-01 |
| Tai Chi, Physiologic Complexity, and Healthy Aging (NCT01340365) | Harvard University Faculty of Medicine | 2011-03-01 |
| Pregabalin on Interleukin-6 Levels in Living Donor Kidney (NCT01529190) | Federal University of São Paulo | 2011-03-01 |
| Safety, Tolerability, and Efficacy of 21 Days Dermal Application of MRX-6 on Mild to Moderate Contact Dermatitis (NCT00867607) | Hadassah Medical Organization | 2011-03-01 |
| Study of ALD-401 Via Intracarotid Infusion in Ischemic Stroke Subjects (NCT01273337) | Aldagen | 2011-03-01 |
| Abraxane With or Without Tigatuzumab in Patients With Metastatic, Triple Negative Breast Cancer (NCT01307891) | University of Alabama at Birmingham | 2011-03-01 |
| A Study of LY2828360 in Patients With Osteoarthritic Knee Pain (NCT01319929) | Eli Lilly and Company | 2011-03-01 |
| Altered Chemotherapy Sequencing During Neoadjuvant Therapy for Patients With Stage II or III Rectal Adenocarcinoma (NCT01302613) | University of Texas Southwestern Medical Center | 2011-03-01 |
| Trial of Outpatient Intravenous Interleukin-2 in Malignant Melanoma and Metastatic Kidney Cancer (NCT01355562) | Loma Linda University | 2011-03-01 |
| Safety and Efficacy Study of Antiviral Local Application to Treat High Grade Cervical Intraepithelial Lesions (CIN2/3) (NCT01303328) | Mithra Pharmaceuticals | 2011-03-01 |
| Efficacy and Safety of Oral Valproic Acid for Retinitis Pigmentosa (NCT01399515) | Seoul National University Hospital | 2011-03-01 |
| Oral Sodium Blood Pressure in Normal Weight, Overweight and Obese Volunteers (NCT01532401) | Poitiers University Hospital | 2011-03-01 |
| Ofatumumab for High-Risk Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) (NCT01243190) | M.D. Anderson Cancer Center | 2011-03-01 |
| Reducing Reconsolidation of Trauma Memories With Propranolol (NCT01349439) | Douglas Mental Health University Institute | 2011-03-01 |
| Reverse Genetic H9N2 Influenza Vaccine Study in Adults (NCT01320696) | Alachua Government Services, Inc. | 2011-03-01 |
| Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis Patients (NCT01663116) | Tigenix S.A.U. | 2011-03-01 |
| Study of Nasal Insulin to Fight Forgetfulness - Long-acting Insulin Detemir - 21 Days (NCT01547169) | University of Washington | 2011-03-01 |
| Vitamin D for Treatment of Glioblastoma Multiforme (NCT01181193) | Soroka University Medical Center | 2011-03-01 |
| A Study to Evaluate Safinamide's Effect on Dopamine and Serotonin's Availability by Using Brain Imaging (NCT01264861) | Newron Pharmaceuticals SPA | 2011-03-01 |
| Green Tea Lozenges for the Management of Dry Mouth (NCT01647737) | Augusta University | 2011-03-01 |
| A Study of Herceptin (Trastuzumab) in Combination With Avastin (Bevacizumab) and Sequential Xeloda (Capecitabine) or Docetaxel in Patients With HER2-Positive Locally Recurrent or Metastatic Breast Cancer (NCT00964704) | Hoffmann-La Roche | 2011-03-01 |
| Study of Cerebrolysin for Treatment of Infants With History of Neonatal Hypoxic Ischemic Encephalopathy (NCT01059461) | Sahar M.A. Hassanein, MD | 2011-03-01 |
| Paraorbital-Occipital Alternating Current Stimulation Therapy of Patients With Post-Chiasmatic Lesions (NCT01418820) | University of Magdeburg | 2011-03-01 |
| Pioglitazone in Early Parkinson's Disease (NCT01280123) | University of Rochester | 2011-03-01 |
| Inducing Remission in Type 1 Diabetes With Alefacept (NCT00965458) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-03-01 |
| Randomized Crossover Study of Neurally Adjusted Ventilatory Assist (NAVA) in Preterm Infants (NCT01389882) | Seoul National University Hospital | 2011-03-01 |
| Overcoming Membrane Transporters to Improve CNS Drug Delivery - Improving Brain Antioxidants After Traumatic Brain Injury (NCT01322009) | University of Pittsburgh | 2011-03-01 |